Immune Endophenotypes in Children With Autism Spectrum Disorder
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Background Autism Spectrum Disorder (ASD) is characterized by social communication deficits and restricted, repetitive patterns of behavior. Varied immunological findings have been reported in children with ASD. To address the question of heterogeneity in immune responses, we sought to examine the diversity of immune profiles within a representative cohort of boys with ASD. Methods Peripheral blood mononuclear cells (PBMC) from male children with ASD (n=50) and from typically developing (TD) age-matched male controls (n=16) were stimulated with either lipopolysaccharide (LPS) or phytohaemagglutinin (PHA). Cytokine production was assessed after stimulation. The ASD study population was clustered into subgroups based on immune responses and assessed for behavioral outcomes. Results Children with ASD who had a pro-inflammatory profile based on LPS stimulation were more developmentally impaired as assessed by the Mullen's Scale of Early Learning (MSEL). They also had greater impairments in social affect as measured by the Autism Diagnostic Observation Schedule (ADOS). These children also displayed more frequent sleep disturbances and episodes of aggression. Similarly, children with ASD and a more activated T cell cytokine profile after PHA stimulation were more developmentally impaired as measured by the MSEL. Conclusions Children with ASD may be phenotypically characterized based upon their immune profile. Those showing either a pro-inflammatory response or increased T cell activation/skewing display a more impaired behavioral profile than children with non-inflamed or non-T cell activated immune profiles. These data suggest that there may be several possible immune subphenotypes within the ASD population that correlate with more severe behavioral impairments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Baio, J., Wiggins, L., Christensen, D. L., Maenner, M. J., Daniels, J., Warren, Z., Kurzius-Spencer, M., Zahorodny, W., Robinson, C., Rosenberg, et al. (2018) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss6706a1 · Cited by 6,078
Neuroglial activation and neuroinflammation in the brain of patients with autism
Vargas, D. L., Nascimbene, C., Krishnan, C., Zimmerman, A. W., & Pardo, C. A. (2005) · Annals of Neurology · doi:10.1002/ana.20315 · Cited by 2,149 · cited 15×
“Children with ASD were placed into groups using a k-median cluster algorithm, with the assumption of three groups (“TH1 skewed”, “TH2 skewed”, and a “non-skewed” group based on cytokine responses following challenge with PHA) (Figure 5A).”
BackgroundInfluentialAutism screening questionnaire: diagnostic validity
Berument, S. K., Rutter, M., Lord, C., Pickles, A., & Bailey, A. (1999) · British Journal of Psychiatry · doi:10.1192/bjp.175.5.444 · Cited by 1,464 · cited 1×
“Inclusion criteria for the TD children included scores on the Lifetime Edition of the Social Communication Questionnaire (26), a screening tool for ASD, below the recommended screening cutoff for young children of 11 and developmental scores within 2 standard deviations of the mean on all subscales of the Mullen Scale…”
MethodAshwood, P., Krakowiak, P., Hertz-Picciotto, I., Hansen, R., Pessah, I., & Van de Water, J. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.08.003 · Cited by 940 · cited 6×
“Children with a more pronounced response to immune stimulation, be it LPS (innate) or PHA (T cell), demonstrate the greatest developmental and behavioral impairments and show differences in core and comorbid behaviors similar to that previously described in a variety of immunological studies in ASD (4, 5, 44).”
BackgroundResultInfluentialSelf-citationRegulation of learning and memory by meningeal immunity: a key role for IL-4
Derecki, N. C., Cardani, A. N., Yang, C. H., Quinnies, K. M., Crihfield, A., Lynch, K. R., & Kipnis, J. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20091419 · Cited by 800 · cited 1×
“TH2 cytokines appear to have a more beneficial function with IL-4 KO mice showing cognitive impairments that can be rescued by transfer of bone marrow from wild type mice (42).”
BackgroundElevated immune response in the brain of autistic patients
Li, X., Chauhan, A., Sheikh, A. M., Patil, S., Chauhan, V., Li, X.-M., Ji, L., Brown, T., & Malik, M. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.12.002 · Cited by 786
The role of immune dysfunction in the pathophysiology of autism
Onore, C., Careaga, M., & Ashwood, P. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.08.007 · Cited by 635
Self-citationShort-Term Benefit From Oral Vancomycin Treatment of Regressive-Onset Autism
Sandler, R. H., Finegold, S. M., Bolte, E. R., Buchanan, C. P., Maxwell, A. P., Väisänen, M.-L., Nelson, M. N., & Wexler, H. M. (2000) · Journal of Child Neurology · doi:10.1177/088307380001500701 · Cited by 614 · cited 1×
“The use of antibiotics to alter gut flora and systemic immune responses has met with similar results, with a minority of children experiencing benefit (47).”
ResultThe immune response in autism: a new frontier for autism research
Ashwood, P., Wills, S., & Van de Water, J. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1205707 · Cited by 528 · cited 1×
“Numerous published findings have identified widespread differences in the immune systems of children with ASD, both at the systemic and cellular levels (3).”
BackgroundSelf-citationCognitive profiles and social‐communicative functioning in children with autism spectrum disorder
Joseph, R. M., Tager‐Flusberg, H., & Lord, C. (2002) · Journal of Child Psychology and Psychiatry · doi:10.1111/1469-7610.00092 · Cited by 503 · cited 6×
“Final diagnosis of ASD was confirmed by the Autism Diagnostic Interview-Revised (ADI-R) (22) and the Autism Diagnostic Observation Schedule (ADOS) (23).”
MethodInfluentialA neuromodulatory role of interleukin-1β in the hippocampus
Schneider, H., Pitossi, F., Balschun, D., Wagner, A., del Rey, A., & Besedovsky, H. O. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7778 · Cited by 498
Cytokine dysregulation in autism spectrum disorders (ASD): Possible role of the environment
Goines, P. E., & Ashwood, P. (2013) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2012.07.006 · Cited by 314 · cited 1×
“Dysregulation in the immune system could increase sensitivity to altered neurologic function from a variety of sources, particularly during early development (6).”
BackgroundSelf-citationMaes, M., Scharpé, S., Meltzer, H. Y., Okayli, G., Bosmans, E., D'Hondt, P., Vanden Bossche, B., & Cosyns, P. (1994) · Psychiatry Research · doi:10.1016/0165-1781(94)90003-5 · Cited by 302
Differential monocyte responses to TLR ligands in children with autism spectrum disorders
Enstrom, A. M., Onore, C. E., Van de Water, J. A., & Ashwood, P. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.08.001 · Cited by 294 · cited 1×
“These findings are in agreement with previously reported findings in cultured monocytes (29) and plasma (4) from children with ASD that found increased production of pro-inflammatory cytokines were associated with more severe behavioral impairments.”
ResultSelf-citationAssociations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders
Ashwood, P., Krakowiak, P., Hertz-Picciotto, I., Hansen, R., Pessah, I. N., & Van de Water, J. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.10.025 · Cited by 279 · cited 1×
“In addition to production of innate inflammatory cytokines in response to LPS, a number of studies have reported increased levels of T-cell-associated cytokines in children with ASD, which are associated with more impaired behaviors (36).”
BackgroundSelf-citationTh1- and Th2-like cytokines in CD4+ and CD8+ T cells in autism
Gupta, S., Aggarwal, S., Rashanravan, B., & Lee, T. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00021-6 · Cited by 250 · cited 14×
“Children with ASD were placed into groups using a k-median cluster algorithm, with the assumption of three groups (“TH1 skewed”, “TH2 skewed”, and a “non-skewed” group based on cytokine responses following challenge with PHA) (Figure 5A).”
InfluentialLow-grade endotoxemia in patients with severe autism
Emanuele, E., Orsi, P., Boso, M., Broglia, D., Brondino, N., Barale, F., di Nemi, S. U., & Politi, P. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.01.033 · Cited by 225 · cited 1×
“These include increased levels of pro-inflammatory cytokines such as IL-1β, TNFα and IL-6, and chemokines such as MCP-1, in plasma, cerebral spinal fluid (CSF) and post mortem brain tissue (4, 16-19).”
BackgroundWills, S., Cabanlit, M., Bennett, J., Ashwood, P., Amaral, D. G., & Van de Water, J. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.07.007 · Cited by 163 · cited 1×
“Importantly, altered immune function in the brain of individuals with ASD is suggested by evidence of neuroglial activation and neuroinflammation in the CNS (7), as well as the presence of antibodies reactive to neuronal tissue (8-12) in a subset of children with ASD.”
BackgroundSelf-citationBrain‐Specific Autoantibodies in the Plasma of Subjects with Autistic Spectrum Disorder
CABANLIT, M., WILLS, S., GOINES, P., ASHWOOD, P., & VAN DE WATER, J. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1381.010 · Cited by 157
Self-citationAntibrain antibodies in children with autism and their unaffected siblings
Singer, H. S., Morris, C. M., Williams, P. N., Yoon, D. Y., Hong, J. J., & Zimmerman, A. W. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.05.025 · Cited by 132 · cited 1×
“Importantly, altered immune function in the brain of individuals with ASD is suggested by evidence of neuroglial activation and neuroinflammation in the CNS (7), as well as the presence of antibodies reactive to neuronal tissue (8-12) in a subset of children with ASD.”
BackgroundStrong association of the third hypervariable region of HLA-DRβ1 with autism
Warren, R. P., Odell, J. D., Warren, W. L., Burger, R. A., Maciulis, A., Daniels, W. W., & Torres, A. R. (1996) · Journal of Neuroimmunology · doi:10.1016/0165-5728(96)00052-5 · Cited by 130
Harden, L. M., Plessis, I. D., Poole, S., & Laburn, H. P. (2008) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.12.006 · Cited by 118
The Association and Linkage of the HLA-A2 Class I Allele with Autism
Torres, A. R., Sweeten, T. L., Cutler, A., Bedke, B. J., Fillmore, M., Stubbs, E. G., & Odell, D. (2006) · Human Immunology · doi:10.1016/j.humimm.2006.01.001 · Cited by 104
Steinhausen, H. ‐., & Erdin, A. (1992) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.1992.tb00908.x · Cited by 32
Cited by
Inflammation in CNS neurodegenerative diseases
Stephenson, J., Nutma, E., van der Valk, P., & Amor, S. (2018) · Immunology · doi:10.1111/imm.12922 · Cited by 966
The gut microbiome: Relationships with disease and opportunities for therapy
Durack, J., & Lynch, S. V. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20180448 · Cited by 943
Jiang, H.-Y., Xu, L.-L., Shao, L., Xia, R.-M., Yu, Z.-H., Ling, Z.-X., Yang, F., Deng, M., & Ruan, B. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.06.005 · Cited by 391
Innate immune dysfunction and neuroinflammation in autism spectrum disorder (ASD)
Hughes, H. K., R.J.Moreno, & Ashwood, P. (2023) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2022.12.001 · Cited by 263
Self-citationSaghazadeh, A., Ataeinia, B., Keynejad, K., Abdolalizadeh, A., Hirbod-Mobarakeh, A., & Rezaei, N. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.05.019 · Cited by 235
Metadata
- Authors
- Careaga, M., Rogers, S., Hansen, R. L., Amaral, D. G., Van de Water, J., & Ashwood, P.
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2017-03
- Volume
- 81
- Issue
- 5
- Pages
- 434-441
- ISSN
- 0006-3223 (ISSN-L)
- OpenAlex
- W2127289457
- Cited by
- 143
- References
- 24
- FWCI
- 6.27
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.